|
RIN2 expression based on
|
KIRP : Kidney renal papillary cell carcinoma
| Comparison | Statistical significance |
| Normal-vs-Primary | 4.359100E-03 |
|
KIRP : Kidney renal papillary cell carcinoma Note
Cancer stage information is not available for 89 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Stage1 |
1.274440E-02 |
| Normal-vs-Stage2 |
2.315200E-01 |
| Normal-vs-Stage3 |
3.159600E-01 |
| Normal-vs-Stage4 |
6.701600E-01 |
| Stage1-vs-Stage2 |
9.717800E-01 |
| Stage1-vs-Stage3 |
7.609600E-01 |
| Stage1-vs-Stage4 |
9.759800E-02 |
| Stage2-vs-Stage3 |
8.499800E-01 |
| Stage2-vs-Stage4 |
2.975400E-01 |
| Stage3-vs-Stage4 |
2.979800E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma Note
Patient race information is not available for 15 samples and two samples from American Indians not included in the above plot.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Caucasian |
6.299800E-03 |
| Normal-vs-AfricanAmerican |
3.621900E-02 |
| Normal-vs-Asian |
1.500590E-01 |
| Caucasian-vs-AfricanAmerican |
9.088600E-01 |
| Caucasian-vs-Asian |
1.894410E-01 |
| AfricanAmerican-vs-Asian |
1.124560E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Male |
4.213900E-02 |
| Normal-vs-Female |
1.559380E-03 |
| Male-vs-Female |
3.688400E-02 |
|
|
KIRP : Kidney renal papillary cell carcinoma Note
Patient BMI information is not available for 72 samples.
| Descriptions |
| Normal weight |
BMI greater than equal to 18.5 and BMI less than 25 |
Extereme weight |
BMI greater than equal to 25 and BMI less than 30 |
| Obese |
BMI greater than equal to 30 and BMI less than 40 |
Extreme Obese |
BMI greater than 40 |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Normal_Weight |
4.998400E-01 |
| Normal-vs-Extreme_Weight |
2.378400E-01 |
| Normal-vs-Obese |
1.696370E-02 |
| Normal-vs-Extreme_Obese |
5.577400E-01 |
| Normal_Weight-vs-Extreme_Weight |
8.187600E-01 |
| Normal_Weight-vs-Obese |
2.070000E-01 |
| Normal_Weight-vs-Extreme_Obese |
3.947600E-01 |
| Extreme_Weight-vs-Obese |
2.089200E-01 |
| Extreme_Weight-vs-Extreme_Obese |
3.020200E-01 |
| Obese-vs-Extreme_Obese |
1.157800E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma Note
Patient age information is not available for 3 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Age(21-40Yrs) |
6.137400E-01 |
| Normal-vs-Age(41-60Yrs) |
6.628900E-04 |
| Normal-vs-Age(61-80Yrs) |
8.054100E-02 |
| Normal-vs-Age(81-100Yrs) |
1.181620E-01 |
| Age(21-40Yrs)-vs-Age(41-60Yrs) |
1.076980E-01 |
| Age(21-40Yrs)-vs-Age(61-80Yrs) |
7.034400E-01 |
| Age(21-40Yrs)-vs-Age(81-100Yrs) |
1.709000E-01 |
| Age(41-60Yrs)-vs-Age(61-80Yrs) |
5.983600E-02 |
| Age(41-60Yrs)-vs-Age(81-100Yrs) |
1.443840E-04 |
| Age(61-80Yrs)-vs-Age(81-100Yrs) |
7.658100E-03 |
|
|
KIRP : Kidney renal papillary cell carcinoma NOTE
Histology information is not available for 17 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-VS-Type1 PRCC |
6.024000E-04 |
| Normal-VS-Type2 PRCC |
8.398800E-01 |
| Normal-VS-KIRP CIMP |
2.714800E-01 |
| Normal-VS-Unclassified PRCC |
1.340780E-03 |
| Type1 PRCC-VS-Type2 PRCC |
4.256500E-03 |
| Type1 PRCC-VS-KIRP CIMP |
6.546300E-02 |
| Type1 PRCC-VS-Unclassified PRCC |
5.813800E-02 |
| Type2 PRCC-VS-KIRP CIMP |
4.755600E-01 |
| Type2 PRCC-VS-Unclassified PRCC |
4.580200E-04 |
| KIRP CIMP-VS-Unclassified PRCC |
8.621500E-04 |
|
Histologic PRCC subtypes: Ricketts CJ et al, The Cancer Genome Atlas Comprehensive Molecular Characterization of Renal Cell Carcinoma. Cell Rep. 2018 Apr 3;23(1):313-326.e5. doi: 10.1016/j.celrep.2018.03.075
|
KIRP : Kidney renal papillary cell carcinoma Note
Nodal metastais status is not available for 1 sample and cancer in nearby lymph nodes cannot be measured (NX) in 211 samples.
| pathologic_N descriptions |
| N0 | No regional lymph node metastasis |
N1 | Metastases in 1 to 3 axillary lymph nodes |
| N2 | Metastases in 4 to 9 axillary lymph nodes |
N3 | Metastases in 10 or more axillary lymph nodes |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-N0 |
8.906400E-01 |
| Normal-vs-N1 |
5.644600E-01 |
| Normal-vs-N2 |
7.153600E-01 |
| N0-vs-N1 |
6.963000E-01 |
| N0-vs-N2 |
8.395800E-01 |
| N1-vs-N2 |
6.786600E-01 |
|
|
